Rephonic
Artwork for Decera Clinical Education Oncology Podcast

Decera Clinical Education Oncology Podcast

Decera Clinical Education
Non-Small Cell Lung Cancer
BTK Inhibitors
Chronic Lymphocytic Leukemia
CAR T-Cell Therapy
Multiple Myeloma
Clinical Trials
Biomarker Testing
Breast Cancer
Bispecific Antibodies
Ovarian Cancer
Her2-Positive Metastatic Breast Cancer
CDK4/6 Inhibitors
Immunotherapy
ROS1
Polycythemia Vera
Essential Thrombocythemia
Mantle Cell Lymphoma
Venetoclax
Endometrial Cancer
NCCN Guidelines

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

PublishesDailyEpisodes246Founded6 years ago
Number of ListenersCategories
Health & FitnessCoursesEducationMedicine

Listen to this Podcast

Artwork for Decera Clinical Education Oncology Podcast

Latest Episodes

In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dosing in outpatient settings, an... more

YouTube

In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis:

• PV and ET increase the risk of both arterial... more

YouTube

In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and polycythemia vera (PV), as well as novel investigational approaches, including the following:

• Ov... more

YouTube

In this podcast episode, Ciro Rinaldi, MD, PhD, and Alessandro M. Vannucchi, MD, as they discuss contemporary topics in diagnosing essential thrombocythemia (ET) and polycythemia vera (PV), including:

• Overview of diagnostic criteria for PV and ET... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Muhamed Baljevic
Director of myeloma program at Vanderbilt
Vanderbilt University Medical Center
Episode: Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma
Jonathan Ticku
Physician at Mayo Clinic
Mayo Clinic
Episode: Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma
Douglas Tremblay
Associate Professor focusing on myeloid malignancies
Mount Sinai School of Medicine
Episode: Thrombotic Events and ET/PV: What You Should Know
Anthony Hunter
Associate Professor focusing on NPNs in the clinic and research
Emory University
Episode: Thrombotic Events and ET/PV: What You Should Know
Ciro Rinaldi
Hematologist at United Lincolnshire Teaching Hospitals
United Lincolnshire Teaching Hospital
Episode: Global Experts Discuss Current and Emerging Treatments for ET and PV
Alessandro Vannucchi
Hematologist at University of Florence
University of Florence
Episode: Global Experts Discuss Current and Emerging Treatments for ET and PV
Asha Miller
Patient advocate, early breast cancer survivor
Independent advocate/clinician collaboration
Episode: Patient Voices: Caring for the Whole Patient and Personalizing Treatment of Early Breast Cancer to Achieve Equitable Outcomes
Kristen Whitaker
Breast oncology physician
MedStar Health
Episode: Patient Voices: Caring for the Whole Patient and Personalizing Treatment of Early Breast Cancer to Achieve Equitable Outcomes
Nadia Harbeck
Director of the Breast Center at LMU University Hospital in Munich
LMU University Hospital
Episode: Role of AKT and PI3K Inhibitors in Patients With HR-Positive Breast Cancers: Experts Share Their Thoughts on Current Practice and Future Opportunities

Host

Decera Clinical Education Oncology Podcast
Decera Clinical Education Oncology Podcast

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#237
Canada/Education/Courses
Apple Podcasts
#34
Argentina/Education/Courses
Apple Podcasts
#56
Japan/Education/Courses
Apple Podcasts
#57
Saudi Arabia/Education/Courses
Apple Podcasts
#86
South Korea/Education/Courses
Apple Podcasts
#118
Sweden/Education/Courses
Apple Podcasts
#139
Hong Kong/Education/Courses
Apple Podcasts
#148
Austria/Education/Courses
Apple Podcasts
#169
India/Education/Courses
Apple Podcasts
#179
South Africa/Education/Courses
Apple Podcasts
#190
Singapore/Education/Courses
Apple Podcasts
#212
Taiwan/Education/Courses

Talking Points

Recent interactions between the hosts and their guests.

Global Experts Discuss Current and Emerging Treatments for ET and PV
Q: How are newer therapies changing the ET/PV landscape, and is there evidence of disease modification?
Second-line agents like oxalitinib and long-acting pegylated interferons show improvements in hematocrit control and symptom burden, and early data suggest possible disease-modifying effects with decreased mutant allele burden in some patients, indicating a shift beyond symptom control toward altering disease biology.
Global Experts Discuss Current and Emerging Treatments for ET and PV
Q: What are the current foundational targets and strategies for PV management?
A hematocrit target of 45% or less, achieved through phlebotomy and often combined with low-dose aspirin, remains central to PV management to reduce thrombosis risk, with stratification into low- and high-risk groups guiding treatment intensity.
Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma
Q: What are the key considerations when selecting patients for outpatient step-up dosing?
They emphasize lower disease burden, stable comorbidity profiles, caregiver support, proximity to emergency services, and infrastructure such as remote monitoring to enable safe outpatient step-ups.
Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer
Q: What are the essential biomarkers to test for colorectal cancer, and how do they influence treatment decisions?
Key biomarkers include MSI/MMR, KRAS, BRAF, HER2, and emerging targets like RET and NTRK; their status guides immunotherapy use, EGFR targeting, and eligibility for clinical trials, shaping decisions from early to metastatic disease.
Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer
Q: Ann Marie, how do you talk to patients about biomarker testing and clarify germline versus somatic testing?
We explain the difference clearly, stressing that germline testing looks for inherited risk shared with family, while somatic testing is tumor-specific and guides treatment decisions; we emphasize the potential impact on family screening and personalized therapy.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

This program delivers practical, clinically focused insights on cancer care, covering a broad spectrum of solid tumors and hematologic malignancies. Recent episodes spotlight advanced practice professionals and biomarker testing, global perspectives on evolving therapies like BTK inhibitors in hematologic diseases, and data-driven discussions on targeted therapies, immunotherapies, and novel treatment sequencing. Notably, the show frequently features physician-scientists and clinicians from major cancer centers, highlighting real-world challenges such as access disparities, testing turnaround times, and patient education. The format tends to combine data from major conferences with pragmatic takeaways for behind-the-chair practice, making i... more

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Two Onc Docs
2. Oncology Today with Dr Neil Love
3. OncLive® On Air
4. JAMA Clinical Reviews
5. JAMA Editors' Summary

How many episodes of this podcast are there?

this podcast launched 6 years ago and published 246 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Muhamed Baljevic
2. Jonathan Ticku
3. Douglas Tremblay
4. Anthony Hunter
5. Ciro Rinaldi
6. Alessandro Vannucchi
7. Asha Miller
8. Kristen Whitaker

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days